1-7 of 7
D Billadeau
Close
Sort by
Journal Articles

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Xiaosheng Wu, Mary Stenson, Jithma Abeykoon, Kevin Nowakowski, Lianwen Zhang, Joshua Lawson, Linda Wellik, Ying Li, Jordan Krull, Kerstin Wenzl, Anne J. Novak, Stephen M. Ansell, Gail A. Bishop, Daniel D. Billadeau, Kah Whye Peng, Francis Giles, Daniel M. Schmitt, Thomas E. Witzig
Journal: Blood
Blood (2019) 134 (4): 363–373.
https://doi.org/10.1182/blood.2018874560
Published: 2019
Includes: Supplemental data
Journal Articles

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma

Clinical Trials & Observations
Rebecca L. Boddicker, Gina L. Razidlo, Surendra Dasari, Yu Zeng, Guangzhen Hu, Ryan A. Knudson, Patricia T. Greipp, Jaime I. Davila, Sarah H. Johnson, Julie C. Porcher, James B. Smadbeck, Bruce W. Eckloff, Daniel D. Billadeau, Paul J. Kurtin, Mark A. McNiven, Brian K. Link, Stephen M. Ansell, James R. Cerhan, Yan W. Asmann, George Vasmatzis, Andrew L. Feldman
Journal: Blood
Blood (2016) 128 (9): 1234–1245.
https://doi.org/10.1182/blood-2016-03-707141
Published: 2016
Includes: Supplemental data
Journal Articles

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells

Andrei V. Ougolkov, Nancy D. Bone, Martin E. Fernandez-Zapico, Neil E. Kay, Daniel D. Billadeau
Journal: Blood
Blood (2007) 110 (2): 735–742.
https://doi.org/10.1182/blood-2006-12-060947
Published: 2007
Journal Articles

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial

P Liu, T Leong, L Quam, D Billadeau, NE Kay, P Greipp, RA Kyle, MM Oken, B Van Ness
Journal: Blood
Blood (1996) 88 (7): 2699–2706.
https://doi.org/10.1182/blood.V88.7.2699.bloodjournal8872699
Published: 1996
Journal Articles

Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma

D Billadeau, B Van Ness, T Kimlinger, RA Kyle, TM Therneau, PR Greipp, TE Witzig
Journal: Blood
Blood (1996) 88 (1): 289–296.
https://doi.org/10.1182/blood.V88.1.289.289
Published: 1996
Journal Articles

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

D Billadeau, L Quam, W Thomas, N Kay, P Greipp, R Kyle, MM Oken, B Van Ness
Journal: Blood
Blood (1992) 80 (7): 1818–1824.
https://doi.org/10.1182/blood.V80.7.1818.1818
Published: 1992
Journal Articles

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease

D Billadeau, M Blackstadt, P Greipp, RA Kyle, MM Oken, N Kay, B Van Ness
Journal: Blood
Blood (1991) 78 (11): 3021–3029.
https://doi.org/10.1182/blood.V78.11.3021.3021
Published: 1991